Total Live Articles: 503

Cerebral Palsy

NICE guideline [NG62] Cerebral palsy in under 25s: assessment and management. Published: Jan 2017.

NICE clinical guideline [CG145] Spasticity in under 19s: management. Last updated: Nov 2016.

NICE guideline [NG25] Preterm labour and birth. Last updated: Jun 2022.

Cerebral Palsy

Definition

Cerebral palsy is an umbrella term for non-progressive, permanent motor disorders caused by: [Ref]

  • Acquired brain injury (~90% of cases), or
  • Abnormal brain development (~10-15% of cases)
  • That occurred in the developing fetal / infant brain (i.e. occurred during the antenatal / perinatal / early postnatal period)

Cerebral palsy is usually multifactorial, with no single identifiable cause in most cases [Ref]

Cerebral palsy is strictly defined by non-progressive insults occurring during early fetal or infant brain development. [Ref]

Brain injuries sustained after this early developmental window (e.g. head injury or stroke in later childhood or adulthood) are classified as acquired brain injuries, not cerebral palsy. [Ref]

Causes and Risk Factors

[Ref][NICE NG62]

Period Important causes / risk factors
Antenatal period (affecting the fetal brain)
Perinatal / neonatal period (around birth and early neonatal life)
  • Neonatal encephalopathy, which may result from
  • Low birth weight
  • Intracranial haemorrhage (e.g. IVH, subgaleal haemorrhage)
  • Severe unconjugated hyperbilirubinaemia → kernicterus
Postnatal period (affecting the developing infant brain)
  • CNS infections (e.g. meningitis, encephalitis)
  • Significant traumatic brain injury, including non-accidental injury
  • Infant stroke

NB Postnatally acquired cerebral palsy refers to brain injury occurring during early brain development, rather than neurological injury occurring later outside this developmental period.

Epidemiological definitions commonly use <2 y/o as the upper limit for post-neonatally acquired cerebral palsy [Ref]

Clinical Features

Cerebral palsy is primarily a motor disorder, characterised by abnormalities in the development of movement and posture, resulting in activity limitation [Ref1][Ref2]

Motor Features

Common motor features include: [Ref1][Ref2]

  • Early features [NICE NG62]
    • Delayed motor development / milestones
    • Absent or abnormal fidgety movements
    • Movement abnormalities (e.g. asymmetry or lack of movement)
    • Abnormal muscle tone (e.g. spasticity, dystonia, fluctuating tone)
    • Feeding difficulties
  • Other motor features that become more apparent with development
    • Abnormal gait
    • Muscle weakness
    • Impaired coordination / selective motor control
    • +/- Involuntary movements (depending on the motor phenotype – see below)

Key milestone red flags for cerebral palsy: [NICE NG62]

  • Not sitting by 8 months
  • Not walking by 18 months
  • Hand preference (early asymmetry of hand function) before 1 year of age (due to possible weakness / spasticity of the contralateral limb)

Use corrected age for those born preterm

Key MSK complications arise from chronic abnormal muscle tone, muscle imbalance and abnormal postures: [Ref]

  • Muscle shortening and fixed contractures
  • Hip dislocation
  • Scoliosis
  • Joint deformity
  • Pain and reduced mobility

Classification by Predominant Motor Phenotype

[Ref1][Ref2][Ref3]

Cerebral palsy phenotype Predominant motor features Classic associations / causes
Spastic – most common Primarily affects: upper motor neuron (corticospinal pathways)

Causes typical upper motor neuron lesion findings:

  • ↑ Tone (hypertonia / spasticity) → abnormal resting postures +/- contractures
  • Spastic weakness → stiff, restricted movements
  • Brisk reflex / hyperreflexia / exaggerated jaw jerk
  • Ankle clonus
  • Babinski sign (extensor plantar responses) or Hoffmann’s sign

Gait changes:

  • Scissoring gait may occur, especially with bilateral lower-limb spasticity
  • Toe-walking may occur
Prematurity / PVL → bilateral spastic cerebral palsy

Hypoxic-ischaemic encephalopathy (can cause both spastic or dyskinetic cerebral palsy, depending on the brain injury pattern)

Perinatal stroke / unilateral cerebral injury → unilateral spastic cerebral palsy

Dyskinetic Primarily affects: basal ganglia / extrapyramidal motor pathways

Primary features: involuntary movements + fluctuating muscle tone

There are 2 main subtypes:

  • Dystonic (↑ tone) → abnormal postures, sustained / intermittent muscle contractions
  • Choreoathetotic (↓ tone) → hyperkinetic, jerky/writhing movements
Hypoxic-ischaemic encephalopathy (can cause both spastic or dyskinetic cerebral palsy, depending on the brain injury pattern)

Kernicterus classically associated with choreoathetotic type

Ataxic Primarily affects: cerebellar system

Causes typical cerebellar features (DANISH):

  • Dysdiadochonkinesia + dysmetria
  • Ataxia
  • Nystagmus
  • Intentional tremor
  • Slurred speech (dysarthria)
  • Hypotonia
Cerebellar injury

Maldevelopment

Cerebral palsy can also be a mixed subtype where there are features of >1 phenotype (e.g. spasticity + involuntary movements)

Associated Non-Motor Features and Comorbidities

[NICE NG62]

Body system Associated features / comorbidities
Neurological / neurodevelopment
Sensory
  • Visual impairment (including strabismus, refractive error) (~1 in 2)
  • Hearing impairment (~1 in 10)
Gastrointestinal Bulbar muscle weakness can result in:

  • Dysphagia (→ coughing / choking / gagging during meals +/- aspiration risk)
  • Feeding difficulties (→ poor nutritional intake / impaired growth)

Other GI features:

  • Saliva drooling (sialorrhoea)
  • GORD / regurgitation / vomiting
  • Constipation (~3 in 5)
Systemic

Investigation and Diagnosis

Cerebral palsy is a clinical diagnosis based on: [NICE NG62]

  • Detailed history including
    • Antenatal, perinatal, postnatal history
    • Developmental progress (esp. motor milestones)
  • Neurological examination

Consider general movement assessment in high-risk infants (0-3 months) [NICE NG62]

MRI may be required: [NICE NG62]

  • MRI is NOT required to confirm the diagnosis; its main role is to investigate the underlying cause
  • MR is indicated when there is no clear cause from the history, developmental progress, examination, and previous cranial ultrasound findings

Red flags suggesting an alternative neurological diagnosis: [NICE NG62]

  • Absence of known causes / risk factors
  • Family history of a progressive neurological disorder (e.g. hereditary spastic paraplegia, mitochondrial disorder)
  • Regression of developmental milestones / attained cognitive function (suggests a progressive neurological / neurodegenerative disorder)
  • Development of unexpected focal neurological signs
  • MRI findings suggestive of a progressive neurological disorder or not in keeping with those of cerebral palsy

If ANY of the above are present, refer to paediatric neurology for further assessment

Management

All children with suspected cerebral palsy should be referred to a child development service for urgent multidisciplinary assessment

Management is individualised and multidisciplinary

Problem / manifestation Management
Problems with movement or posture (spasticity-related) [NICE CG145] Mainstay: physiotherapy +/- occupational therapy

Consider orthoses to improve posture / function and reduce risk of contracture and hip dislocation

Pharmacological adjuncts:

  • Oral baclofen – for longer-term relief of spasms
  • Diazepam – for rapid relief of painful spasms
  • Botulinum toxin A – for problematic focal spasticity / selected focal dystonia

In severe refractory cases, seek specialist opinion regarding options like intrathecal baclofen, orthopaedic surgery, selective dorsal rhizotomy

Drooling / saliva control [NICE NG62] First, assess reversible contributors (e.g. positioning, reflux, dental problems, medications)

Choice of therapy:

  • 1st line: anticholinergic (e.g. glycopyrronium, transdermal hyoscine)
  • 2nd line: botulinum toxin A to the salivary glands
  • 3rd line: specialist surgical assessment
Eating, drinking, or swallowing difficulties Involve speech and language therapy

If there are concerns regarding poor nutrition / impaired growth:

  • Refer to dietitian
  • Monitor growth and nutritional status
  • Optimise oral intake where safe
  • Consider enteral feeding if adequate nutrition cannot be achieved orally
Speech, language, or communication difficulties Involve speech and language therapy
Low bone mineral density Optimise nutrition, calcium and vitamin D

Encourage appropriate active movement / weight-bearing where possible

Also see the  Osteoporosis article

Sleep disturbances Optimise sleep hygiene

Assess for / manage contributors to sleep disturbances (e.g. pain, seizures, positioning problems, OSA, medication effects)

Consider melatonin, esp. for sleep-onset problems

Pain, discomfort, and distress Assess for and manage any underlying causes, such as spasticity / dystonia, hip displacement, scoliosis, constipation, GORD
Visual and hearing impairment ALL children with cerebral palsy should have a baseline ophthalmological + orthoptic assessment upon diagnosis

Arrange ongoing regular hearing assessment

Epilepsy Manage as per the Seizures and Epilepsy in Adults and Childhood Onset Epilepsy articles
Constipation Assess for constipation regularly and manage accordingly
GORD Manage as per the Gastro-Oesophageal Reflux Disease (GORD) and Gastro-Oesophageal Reflux Disease (GORD) in Children articles
Mental health or behavioural problems Identify and manage problems, such as:

Prevention

In preterm labour, antenatal IV magnesium sulfate (to the mother) can be given for fetal neuroprotection (reduces risk of cerebral palsy) [NICE NG25]

  • Consider if 30+0 – 33+6 weeks
  • Offer if 24+0 – 29+6 weeks

See the PROM, P-PROM, and Preterm Labour article for more information

References

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

This is a staging environment

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.